These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8943142)

  • 1. Dynamic magnetic resonance imaging in the study of vocal tract configuration.
    Crary MA; Kotzur IM; Gauger J; Gorham M; Burton S
    J Voice; 1996 Dec; 10(4):378-88. PubMed ID: 8943142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of symptoms for spasmodic dysphonia and vocal tremor: a comparison of expert and nonexpert judges.
    Barkmeier JM; Case JL; Ludlow CL
    J Commun Disord; 2001; 34(1-2):21-37. PubMed ID: 11322567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results of recurrent laryngeal nerve resection for adductor spasmodic dysphonia.
    Fritzell B; Hammarberg B; Schiratzki H; Haglund S; Knutsson E; Mårtensson A
    J Voice; 1993 Jun; 7(2):172-8. PubMed ID: 8353632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of botulinum toxin in the treatment of adductor spasmodic dysphonia.
    Whurr R; Lorch M; Fontana H; Brookes G; Lees A; Marsden CD
    J Neurol Neurosurg Psychiatry; 1993 May; 56(5):526-30. PubMed ID: 8505645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vocal Parameters and Self-Perception in Individuals With Adductor Spasmodic Dysphonia.
    Rojas GVE; Ricz H; Tumas V; Rodrigues GR; Toscano P; Aguiar-Ricz L
    J Voice; 2017 May; 31(3):391.e7-391.e18. PubMed ID: 27866691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vestibular vocal fold behavior during phonation in unilateral vocal fold paralysis.
    Pinho SM; Pontes PA; Gadelha ME; Biasi N
    J Voice; 1999 Mar; 13(1):36-42. PubMed ID: 10223673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a telephone screening tool for spasmodic dysphonia and vocal fold tremor.
    Johnson DM; Hapner ER; Klein AM; Pethan M; Johns MM
    J Voice; 2014 Nov; 28(6):711-5. PubMed ID: 24962230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of muscle activation patterns in adductor and abductor spasmodic dysphonia.
    Van Pelt F; Ludlow CL; Smith PJ
    Ann Otol Rhinol Laryngol; 1994 Mar; 103(3):192-200. PubMed ID: 8122835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Abnormal adductor movement of the vocal cords in spasmodic dysphonia].
    Shibusawa M
    Nihon Jibiinkoka Gakkai Kaiho; 1993 Apr; 96(4):659-64. PubMed ID: 8509938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spasmodic dysphonia combined with insufficient glottic closure by phonation.
    Kaszás Z; Lichtenberger G; Mészáros K; Falvai J
    Eur Arch Otorhinolaryngol; 2003 Sep; 260(8):418-20. PubMed ID: 12709812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spastic/spasmodic vs. tremulous vocal quality: motor speech profile analysis.
    Lundy DS; Roy S; Xue JW; Casiano RR; Jassir D
    J Voice; 2004 Mar; 18(1):146-52. PubMed ID: 15070235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neck surface electromyography as a measure of vocal hyperfunction before and after injection laryngoplasty.
    Stepp CE; Heaton JT; Jetté ME; Burns JA; Hillman RE
    Ann Otol Rhinol Laryngol; 2010 Sep; 119(9):594-601. PubMed ID: 21033026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of neuromuscular activity on the response to botulinum toxin injections in spasmodic dysphonia.
    Wong DL; Adams SG; Irish JC; Durkin LC; Hunt EJ; Charlton MP
    J Otolaryngol; 1995 Aug; 24(4):209-16. PubMed ID: 8551532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The evaluation of voice and aerodynamic activity of larynx in patients with vocal cords atrophy].
    Kosztyła-Hojna B
    Pol Merkur Lekarski; 2005 Feb; 18(104):151-5. PubMed ID: 17877119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adductor muscle activity abnormalities in abductor spasmodic dysphonia.
    Cyrus CB; Bielamowicz S; Evans FJ; Ludlow CL
    Otolaryngol Head Neck Surg; 2001 Jan; 124(1):23-30. PubMed ID: 11228447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined-modality treatment of adductor spasmodic dysphonia with botulinum toxin and voice therapy.
    Murry T; Woodson GE
    J Voice; 1995 Dec; 9(4):460-5. PubMed ID: 8574315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The vocal tract model of placement: II. Acoustic aspects.
    Nichols AC
    J Commun Disord; 1986 Aug; 19(4):281-8. PubMed ID: 3745489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interarytenoid muscle botox injection for treatment of adductor spasmodic dysphonia with vocal tremor.
    Kendall KA; Leonard RJ
    J Voice; 2011 Jan; 25(1):114-9. PubMed ID: 20137891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spasmodic dysphonia symptoms as initial presentation of amyotrophic lateral sclerosis.
    Roth CR; Glaze LE; Goding GS; David WS
    J Voice; 1996 Dec; 10(4):362-7. PubMed ID: 8943140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of vocal hyperfunction on relative fundamental frequency during voicing offset and onset.
    Stepp CE; Hillman RE; Heaton JT
    J Speech Lang Hear Res; 2010 Oct; 53(5):1220-6. PubMed ID: 20643798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.